Work

The Orexin 2 Receptor Agonist ALKS 2680 in Patients with Narcolepsy Type 1: An Initial Proof of Concept Phase 1b Study (P8-4.004)

Year: 2025

Type: article

Study design: Clinical Trial

Source: Neurology

DOI: 10.1212/wnl.0000000000210498

Authors: Ron Grunstein, Brendon Yee, Julia Chapman, Angela D’Rozario, Craig Hopkinson, Jandira Ramos, Daniel Smith, Sergey Yagoda, Bhaskar Rege

Institutions: Woolcock Institute of Medical Research, Alkermes (United States)

Language: English

Topic: Sleep and Wakefulness Research

Subfield: Cognitive Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409227062

FWCI: 1.096

Cites:

Cited by: 2

Related to: 10